Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
A Phase 1/Phase 2 Trial to Evaluate Safety, Immunogenicity and PSA Response of VTP-850 Prostate Cancer Immunotherapeutic in Men with Biochemical Recurrence after Definitive Local Therapy for Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 18, 2024
A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor Monotherapy in Subjects with JAK Inhibitor-Naïve Myelofibrosis and Moderate Thrombocytopenia
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 26, 2024
The Pain Identification and Communication Toolkit: A Training Program to Support Family Caregivers of Persons with Alzheimer’s Disease and Related Dementias
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 13, 2024
An Open-Label, Multicenter, Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 13, 2024
A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23 Pathway to Establish Efficacy in Pediatric Crohn’s Disease (Macaroni-23)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 13, 2024
A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 As Monotherapy In Subjects With Mature B-Cell Malignancies
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 13, 2024
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety and Efficacy Of Efruxifermin In Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 13, 2024
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 27, 2024
A Phase 1, Open-Label, Multicenter Study of JANX007 in Subjects with Metastatic Castration-Resistant Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 29, 2024
A Two-Stage, Randomized, Controlled Trial Comparing the Safety and Efficacy of Iltamiocel with Placebo in the Treatment of Female Participants with Chronic Fecal Incontinence and a History of Obstetric Anal Sphincter Injury (DigniFI)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 4, 2024
« first
‹ previous
…
20
21
22
23
24
(current)
25
26
27
28
next ›
last »